Africa Corporate Wellness Market, by End User, 2018-2027
| Label | USD Million |
|---|---|
| 2018 | 80.39670132349299 USD Million |
| 2019 | 83.9376402726396 USD Million |
| 2020 | 87.8071417194198 USD Million |
| 2021 | 91.55408809655565 USD Million |
| 2022 | 95.87467415712858 USD Million |
| 2023 | 100.62906857135744 USD Million |
| 2024 | 105.8703400050736 USD Million |
| 2025 | 111.65951274747776 USD Million |
| 2026 | 118.06695683471338 USD Million |
| 2027 | 125.17405464955796 USD Million |
| 2028 | 133.06809762671122 USD Million |
| 2029 | 141.86508899881684 USD Million |
| 2030 | 174.82107502314648 USD Million |
| 2031 | 186.37831163359033 USD Million |
| 2032 | 198.699584948717 USD Million |
Data Source: Wantstats Repository
Market Dynamics
Mexico dry eye syndrome (DES) market outlook indicates that it is expected to be a growing sector over the next few years. DES affects an estimated 10% of the Mexican population and affects patients of different ages, genders, and backgrounds. Currently, there is a lack of awareness and infrastructure to manage DES in the country, with more information needed to understand the burden and best practices to manage the condition. The Mexico DES market is currently dominated by a few large ophthalmic companies, with only limited competition. However, as the demand for specialized eye care increases, so too does the number of manufacturers of ophthalmology-related products. As more small- to medium-size companies enter the market, price competition could grow, as well as more specialized products tailored to Mexico’s population and individual needs. Additionally, the demand from emerging healthcare clinics in the country could contribute to increased sales volume. In terms of therapeutic treatments, a variety of products, including lubricants, tear stimulator, and cyclosporine-based eye drops are available in Mexico. Pharmacological treatments such as oral medications, including anticholinergic and antiglaucoma were also observed on the market.
Non-pharmacological approaches such as hydramed therapy, hot compresses, home-made eyecup, and physiotherapy show potential for DES therapy in Mexico. In Mexico, there is a lack of government regulations to ensure the safety of ophthalmic products and personnel in the manufacture, distribution and use of these products. Although a 2017 regulation stipulates the mandatory scientific and technical evaluation of medical products and materials for diagnosis and treatment, its implementation is uncertain. Therefore, collaboration between the government, researchers and industry stakeholders is essential to improve the accessibility and affordability of eye care services and products. Overall, the outlook of Mexico’s DES market is promising – as more research and product offerings appear on the market, it is expected to become a more lucrative sector. The need for increased awareness and access to quality eye care services is especially important in a market that is lacking in both infrastructure and knowledge regarding DES management and treatment.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



